相关实验视频
Updated: May 16, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
359
血栓生成和凝块溶解时间用于预测经过过导管大动脉植入的患者的结果
Aleksander Siniarski1,2, Jakub Michal Zimodro3, Aleksandra Gąsecka4
1Department of Coronary Artery Disease and Heart Failure, Faculty of Medicine, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Journal of thrombosis and thrombolysis
|April 5, 2025
概括
血栓生成标志物,特别是透气管后的大动脉植入 (TAVI) 血栓度峰值,可以预测主要不良心脏和脑血管事件 (MACCE). 前TAVI延迟时间也显示了在接受TAVI的患者中对MACCE的预测价值.
科学领域:
- 心血管医学 心血管医学
- 血液静止和血栓形成
- 干预心脏病学 干预心脏病学
背景情况:
- 过导管大动脉植入 (TAVI) 是高风险患者严重大动脉狭窄的关键治疗方法.
- 塔维可能会影响血栓生成和血栓溶解.
- 预测TAVI后的结果对于患者管理至关重要.
研究的目的:
- 评估TAVI结果中血栓生成和凝块溶解时间的预测能力.
- 为了确定新的生物标志物来预测TAVI后的主要不良心脏和脑血管事件 (MACCE).
主要方法:
- 评估了135名被转诊TAVI的患者,其中70人接受了手术.
- 评估血栓生成 (延迟时间,达到峰值的时间,峰值血栓度,内源性血栓潜力) 和血块溶解时间在TAVI前和出院时.
- 监测MACCE,包括死亡,心脏病发作,中风和心力衰竭,1年.
主要成果:
- 在70名患者中,有14名患者 (20%) 在361天的中位随访期内经历了MACCE.
- 在MACCE和没有MACCE的患者之间,前TAVI血栓生成和凝块溶解是相似的.
- 在TAVI后的峰值血栓度在MACCE患者 (157.5vs240.38nM) 和预测MACCE患者 (157.5vs240.38nM) 中显着较低,预测MACCE (AUC:0.773).
- 前TAVI滞后时间也是MACCE的一个不变的预测因素 (OR:5.304).
结论:
- 在TAVI患者中,TAVI后的峰值血栓度和TAVI前的滞后时间可能作为MACCE的新型预测因素.
- 这些静血标志物需要进一步研究,以便在TAVI管理中临床应用.
相关概念视频
Clot Retraction and Fibrinolysis
3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
570
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
570
Coagulation
3.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.8K
Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K

